Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
What to know about voluntary chocolate recall - 2The Best Computer games for Multiplayer Fun
- 3Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- 4Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title
- 5Russia patents space station designed to generate artificial gravity
- 5 Great Home Remodel Administrations With Green Arrangements In 2024
- Independence from the rat race for Recent college grads: Systems and Tips
- How do my eyes adjust to the dark and how long does it take?
- Your big brain makes you human – count your neurons when you count your blessings
- 4 Dazzling And Well known Island Objections In US
- Gauging the Upsides and downsides of Visas: A Complete Aide
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- 41 Young Men Die in South Africa After Circumcision Initiation
- Israeli Chief of Staff declares new border with Gaza Strip
